About this Author
DBL%20Hendrix%20small.png College chemistry, 1983

Derek Lowe The 2002 Model

Dbl%20new%20portrait%20B%26W.png After 10 years of blogging. . .

Derek Lowe, an Arkansan by birth, got his BA from Hendrix College and his PhD in organic chemistry from Duke before spending time in Germany on a Humboldt Fellowship on his post-doc. He's worked for several major pharmaceutical companies since 1989 on drug discovery projects against schizophrenia, Alzheimer's, diabetes, osteoporosis and other diseases. To contact Derek email him directly: Twitter: Dereklowe

Chemistry and Drug Data: Drugbank
Chempedia Lab
Synthetic Pages
Organic Chemistry Portal
Not Voodoo

Chemistry and Pharma Blogs:
Org Prep Daily
The Haystack
A New Merck, Reviewed
Liberal Arts Chemistry
Electron Pusher
All Things Metathesis
C&E News Blogs
Chemiotics II
Chemical Space
Noel O'Blog
In Vivo Blog
Terra Sigilatta
BBSRC/Douglas Kell
Realizations in Biostatistics
ChemSpider Blog
Organic Chem - Education & Industry
Pharma Strategy Blog
No Name No Slogan
Practical Fragments
The Curious Wavefunction
Natural Product Man
Fragment Literature
Chemistry World Blog
Synthetic Nature
Chemistry Blog
Synthesizing Ideas
Eye on FDA
Chemical Forums
Symyx Blog
Sceptical Chymist
Lamentations on Chemistry
Computational Organic Chemistry
Mining Drugs
Henry Rzepa

Science Blogs and News:
Bad Science
The Loom
Uncertain Principles
Fierce Biotech
Blogs for Industry
Omics! Omics!
Young Female Scientist
Notional Slurry
Nobel Intent
SciTech Daily
Science Blog
Gene Expression (I)
Gene Expression (II)
Adventures in Ethics and Science
Transterrestrial Musings
Slashdot Science
Cosmic Variance
Biology News Net

Medical Blogs
DB's Medical Rants
Science-Based Medicine
Respectful Insolence
Diabetes Mine

Economics and Business
Marginal Revolution
The Volokh Conspiracy
Knowledge Problem

Politics / Current Events
Virginia Postrel
Belmont Club
Mickey Kaus

Belles Lettres
Uncouth Reflections
Arts and Letters Daily
In the Pipeline: Don't miss Derek Lowe's excellent commentary on drug discovery and the pharma industry in general at In the Pipeline

In the Pipeline

« Malcolm Gladwell on Synta and Oncology | Main | Unlovely Polyphenols »

May 10, 2010

Bill Gates Put Some Money On Schrödinger

Email This Entry

Posted by Derek

My take on the recent news that Bill Gates has invested ten million dollars in the computational drug design company Schrödinger is here at Nature News. (They've recently made all their stories open-access, by the way, so you don't need a subscription to get the full stories).

In short, I think that patient billionaire money is just the sort of thing the field needs, because anyone with a short timeline and a need for a good return is going to have a rough time of it. . .

Comments (7) + TrackBacks (0) | Category: In Silico


1. Matt Winkelmann on May 10, 2010 9:05 AM writes...

Met a representative from Schroedinger last week and if I understood her correctly, the Gates money goes exclusively to basic research (i. e. protein structure prediction). They're hiring a bunch of scientists for this purpose.

Permalink to Comment

2. metaphysician on May 10, 2010 10:47 AM writes...

#1- Sounds like smart investing to me. Thats exactly where the money will do the most good, 10-20 years down the road.

Permalink to Comment

3. Far from the mothership on May 10, 2010 3:17 PM writes...

Their press release:

Permalink to Comment

4. Doug on May 10, 2010 6:11 PM writes...

Am I the only one thinking the drug in Schrödinger's box is effective and not at the same time until you open the box?

Sorry, been one of those days.

Permalink to Comment

5. Crazed_modeler on May 11, 2010 1:09 AM writes...


Given the company's name, you would think they would be involved in quantum computing ;-)

In related but off topic news, Bill Gates is also funding a project to suck up seawater and spray it into the air.

Permalink to Comment

6. Skeptic on May 11, 2010 1:11 PM writes...

Of course The Computationalists will defeat The Chemists. Why?

Because The Computationalists aren't resource burners like The Chemists. Thats all that is required. Anything else is gravy.

When you don't have a competitive energy infrastructure what other outcome would you expect?

Permalink to Comment

7. MC on May 11, 2010 2:47 PM writes...

He's invested in biotechs before. When I worked in Seattle, I know he (and Paul Allen) invested in a biotech called Darwin. A chemist that I knew was actually doing chromatography and turned around and Bill and Paul were watching him and he had to explain to them the concept of flash chromatography.

Permalink to Comment


Remember Me?


Email this entry to:

Your email address:

Message (optional):

The Last Post
The GSK Layoffs Continue, By Proxy
The Move is Nigh
Another Alzheimer's IPO
Cutbacks at C&E News
Sanofi Pays to Get Back Into Oncology
An Irresponsible Statement About Curing Cancer
Oliver Sacks on Turning Back to Chemistry